stoxline Quote Chart Rank Option Currency Glossary
  
Schrödinger, Inc. (SDGR)
31.95  -0.31 (-0.96%)    12-08 16:00
Open: 31.75
High: 32.49
Volume: 532,020
  
Pre. Close: 32.26
Low: 31.35
Market Cap: 2,301(M)
Technical analysis
2023-12-08 4:45:57 PM
Short term     
Mid term     
Targets 6-month :  39.2 1-year :  45.79
Resists First :  33.56 Second :  39.2
Pivot price 31.33
Supports First :  28.63 Second :  25.59
MAs MA(5) :  32.02 MA(20) :  30.85
MA(100) :  32.54 MA(250) :  30.86
MACD MACD :  1.3 Signal :  1.3
%K %D K(14,3) :  70.6 D(3) :  70
RSI RSI(14): 62
52-week High :  59.24 Low :  16.4
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ SDGR ] has closed below upper band by 30.8%. Bollinger Bands are 66.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 32.52 - 32.71 32.71 - 32.88
Low: 30.93 - 31.13 31.13 - 31.31
Close: 31.66 - 31.98 31.98 - 32.28
Company Description

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Headline News

Fri, 08 Dec 2023
Schrödinger, Inc. (NASDAQ:SDGR) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Thu, 07 Dec 2023
KeyCorp Comments on Schrödinger, Inc.'s FY2023 Earnings (NASDAQ:SDGR) - MarketBeat

Tue, 05 Dec 2023
Schrodinger Inc (SDGR) Up 2.23% in Premarket Trading - InvestorsObserver

Fri, 24 Nov 2023
Is Schrodinger Inc (SDGR) a Smart Choice in Health Information Services Friday? - InvestorsObserver

Fri, 17 Nov 2023
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Thu, 02 Nov 2023
Schrödinger, Inc. (NASDAQ:SDGR) Q3 2023 Earnings Call Transcript - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Health Information Services
Shares Out 63 (M)
Shares Float 61 (M)
Held by Insiders 6.3 (%)
Held by Institutions 83.9 (%)
Shares Short 6,600 (K)
Shares Short P.Month 6,800 (K)
Stock Financials
EPS 0.56
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 7.82
Profit Margin 22.1 %
Operating Margin -132.1 %
Return on Assets (ttm) -15.2 %
Return on Equity (ttm) 8.6 %
Qtrly Rev. Growth 15.1 %
Gross Profit (p.s.) 1.6
Sales Per Share 3.17
EBITDA (p.s.) -2.73
Qtrly Earnings Growth 0 %
Operating Cash Flow -124 (M)
Levered Free Cash Flow -64 (M)
Stock Valuations
PE Ratio 57.05
PEG Ratio -11.9
Price to Book value 4.08
Price to Sales 10.07
Price to Cash Flow -16.15
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android